Arquivos International News 95w3d Página 11 de 12

Swedish Chordate Medical receives CE mark approval for neuromodulation treatment of Chronic Migraine 5y1y61

11/05/2021 Deixe um comentário 685n4s

Chordate Medical Holding AB (publ) (“the company, or “Chordate”) is a Swedish medical technology company that has developed and patented an innovative treatment method: K.O.S. The company’s existing EC-certificate for K.O.S has now been granted an extension with the indication Chronic Migraine and the intended use: Preventive treatment of chronic migraine in adults over 18 years. The CE marking means that the K.O.S treatment meets the clinical efficacy and safety requirements for in the European Medical Devices Directive for the new indication. The approval allows Chordate to commercialize the migraine treatment within the EU. This CE marking comes one year ahead of the company’s preliminary plan.

Leia Mais »

Better access to dental care could help Brazil win battle against COPD 554e4d

06/05/2021 Deixe um comentário

06 May 2021

Oral health in Brazil needs better promotion and more accessible public dental services, in order to help tackle the impact of Chronic Obstructive Pulmonary Disease (COPD) – the country’s third leading cause of adult death, according to a new study.

Leia Mais »

China’s fast-track regulatory reforms face difficulties in attracting non-Chinese companies, says GlobalData j113g

04/05/2021 Deixe um comentário

China has reformed its regulatory system in recent years to include various fast-track programs similar to the US, EU, and Japan to incentivize the development of drugs for unmet medical needs and serious conditions. However, only a few companies based outside of China have been granted priority review status by the National Medical Products istration (NMPA) for their drug applications, says GlobalData, a leading data and analytics company.

Leia Mais »

Marchesini Group closed 2019 with a consolidated turnover of 441 million Euro, a repeat of the performance in 2018 51f6k

28/07/2020 Deixe um comentário

Marchesini Group closed 2019 with a consolidated turnover of 441 million Euro, a repeat of the excellent performance in 2018. Leia Mais »

Marchesini Group presents ‘X DAYS 2020’ 6c3j1a

18/05/2020 Deixe um comentário

Pianoro (Bologna) – Now, more than ever, we need some extraordinary events to keep in touch. In May, Marchesini Group should have welcomed its customers at its exhibition booth at the German trade show Interpack, where it should have illustrated the new technologies exploited to package pharmaceutical and cosmetic products. Leia Mais »

ASME announced that it will take steps to limit the spread of the coronavirus 3y6l23

13/03/2020 Deixe um comentário

By Rodolfo Cosentino. Leia Mais »

Interphex 2020: the Marchesini Group focuses on serialization and inspection machines 182z3s

14/02/2020 Deixe um comentário

West Caldwell (New Jersey) – February 10^th, 2020 – The Marchesini Group returns to the Jacob K. Javits Center in New York (April 28-30) for the 41^th edition of Interphex, the premier pharmaceutical, biotechnology and device development and manufacturing event in the U.S.
Leia Mais »

Pharma companies seek hike in drug rates under price control 5i394u

12/12/2019 Deixe um comentário

With a 50-200% rise in the cost of raw materials imported from China, pharmaceutical lobby groups have urged the government to invoke extraordinary powers to hike prices of drugs under price control, according to sources. Leia Mais »

Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure 5w6x5y

11/11/2019 Deixe um comentário

New England Journal of Medicine publishes primary endpoint analysis from ongoing Phase 3 study of Takeda’s dengue vaccine candidate. Leia Mais »

Rare diseases: Over 300 million patients affected worldwide 4h5f3x

28/10/2019 Deixe um comentário

Rare diseases represent a global problem. Until now, the lack of data made it difficult to estimate their prevalence. Created and coordinated by Inserm, the Orphanet database, which contains the largest amount of epidemiological data on these diseases taken from the scientific literature, has made it possible to obtain a global estimate.

Leia Mais »